Formulations for Intermittent Release of Parathyroid Hormone (1-34) and Local Enhancement of Osteoblast Activities

REFERENCES

• JT PottsJr, GW Tregear, HT Keutmann, HD Niall, R Sauer, LJ Deftos, BF Dawson, ML Hogan, and GD Aurbach. (1971). Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc. Natl. Acad. Sci. USA. 68:63–67.
   PubMed Web of Science ®Google Scholar
• R Podbesek, C Edouard, PJ Meunier, JA Parsons, J Reeve, RW Stevenson, and JM Zanelli. (1983). Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology. 112:1000–1006.
   PubMed Web of Science ®Google Scholar
• JM Hock, and I Gera. (1992). Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res. 7:65–72.
   PubMed Web of Science ®Google Scholar
• T Uzawa, M Hori, S Ejiri, and H Ozawa. (1995). Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone. Bone. 16:477–484.
   PubMed Web of Science ®Google Scholar
• BR MacDonald, JA Gallagher, and RG Russell. (1986). Parathyroid hormone stimulates the proliferation of cells derived from human bone. Endocrinology. 118:2445–2449.
   PubMed Web of Science ®Google Scholar
• A Scutt, C Duvos, J Lauber, and H Mayer. (1994). Time-dependent effects of parathyroid hormone and prostaglandin E2 on DNA synthesis by periosteal cells from embryonic chick calvaria. Calcif. Tissue. Int. 55:208–215.
   PubMed Web of Science ®Google Scholar
• Y Nakatani, M Tsunoi, Y Hakeda, N Kurihara, K Fujita, and M Kumegawa. (1984). Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 123:894–898.
   PubMed Web of Science ®Google Scholar
• JW Jongen, MP Bos, JM van der Meer, and MP Herrmann-Erlee. (1993). Parathyroid hormone-induced changes in alkaline phosphatase expression in fetal calvarial osteoblasts: differences between rat and mouse. J. Cell. Physiol. 155:36–43.
   PubMed Web of Science ®Google Scholar
• T Ishizuya, S Yokose, M Hori, T Noda, T Suda, S Yoshiki, and A Yamaguchi. (1997). Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest. 99:2961–2970.
   PubMed Web of Science ®Google Scholar
• AB Hodsman, LJ Fraher, T Ostbye, JD Adachi, and BM Steer. (1993). An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J. Clin. Invest. 91:1138–1148.
   PubMed Web of Science ®Google Scholar
• IU Schmidt, H Dobnig, and RT Turner. (1995). Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology. 136:5127–134.
   PubMed Web of Science ®Google Scholar
• NE Lane, DB Kimmel, MH Nilsson, FE Cohen, S Newton, RA Nissenson, and GJ Strewler. (1996). Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model. J. Bone Miner. Res. 11:614–625.
   PubMed Web of Science ®Google Scholar
• H Dobnig, and RT Turner. (1995). Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 136:3632–3638.
   PubMed Web of Science ®Google Scholar
• RL Jilka, RS Weinstein, T Bellido, P Roberson, AM Parfitt, and SC Manolagas. (1999). Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104:439–446.
   PubMed Web of Science ®Google Scholar
• A Kikuchi, and T Okano. (2002). Pulsatile drug release control using hydrogels. Adv. Drug Deliv. Rev. 54:53–77.
   PubMed Web of Science ®Google Scholar
• PI Lee. (1986). Initial concentration distribution as a mechanism for regulating drug release from diffusion controlled and surface erosion controlled matrix systems. J. Control. Rel. 4:1–7.
   Google Scholar
• X Xu, and PI Lee. (1993). Programmable drug delivery from an erodible association polymer system. Pharm. Res. 10:1144–1152.
   PubMed Web of Science ®Google Scholar
• AT Raiche, and DA Puleo. (2003). Association polymers for modulated release of bioactive proteins. IEEE Eng. Med. Biol. Mag. 22:37–41.
   PubMedGoogle Scholar
• JH Jeon, MV Thomas, and DA Puleo. (2007). Bioerodible devices for intermittent release of simvastatin acid. Int. J. Pharm. 340:6–12.
   PubMedGoogle Scholar
• JH Jeon, WT Piepgrass, Y-L Lin, MV Thomas, and DA Puleo. (2008). Localized intermittent delivery of simvastatin hydroxyacid stimulates bone formation in rats. J. Periodontol. 79:1457–1464.
   PubMed Web of Science ®Google Scholar
• AT Raiche, and DA Puleo. (2004). Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J. Biomed. Mater. Res. Part A 69A:342–350.
   Web of Science ®Google Scholar
• DH Kohn, M Sarmadi, JI Helman, and PH Krebsbach. (2002). Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. J. Biomed. Mater. Res. 60:292–299.
   PubMed Web of Science ®Google Scholar
• S Disthabanchong, KJ Martin, CL McConkey, and EA Gonzalez. (2002). Metabolic acidosis up-regulates PTH/PTHrP receptors in UMR 106-01 osteoblast-like cells. Kidney Int. 62:1171–1177.
   PubMed Web of Science ®Google Scholar
• V Codrons, F Vanderbist, RK Verbeeck, M Arras, D Lison, V Preat, and R Vanbever. (2003). Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats. J. Pharm. Sci. 92:938–950.
   PubMed Web of Science ®Google Scholar
• G Wei, GJ Pettway, LK McCauley, and PX Ma. (2004). The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials. 25:345–352.
   PubMed Web of Science ®Google Scholar
• JP Raymond, R Isaac, RE Merceron, and F Wahbe. (1982). Comparison between the plasma concentrations of prolactin and parathyroid hormone in normal subjects and in patients with hyperparathyroidism or hyperprolactinemia. J. Clin. Endocrinol. Metab. 55:1222–1225.
   PubMed Web of Science ®Google Scholar
• KL Hamann, and NE Lane. (2006). Parathyroid hormone update. Rheum. Dis. Clin. North Am. 32:703–719.
   PubMed Web of Science ®Google Scholar
• S Fukayama, E Schipani, H Juppner, B Lanske, HM Kronenberg, AB Abou-Samra, and F.R Bringhurst. (1994). Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology. 134:1851–1858.
   PubMed Web of Science ®Google Scholar
• I Yamamoto, C Shigeno, JT PottsJr, and GV Segre. (1988). Characterization and agonist-induced down-regulation of parathyroid hormone receptors in clonal rat osteosarcoma cells. Endocrinology. 122:1208–1217.
   PubMed Web of Science ®Google Scholar
• JS Patton, P Trinchero, and RM Platz. (1994). Bioavailability of pulmonary delivered peptides and proteins-a-interferon, calcitonins and parathyroid hormones. J. Control. Rel. 28:79–85.
   Web of Science ®Google Scholar
• A Leone-Bay, M Sato, D Paton, AH Hunt, D Sarubbi, M Carozza, J Chou, J McDonough, and RA Baughman. (2001). Oral delivery of biologically active parathyroid hormone. Pharm. Res. 18:964–970.
   PubMed Web of Science ®Google Scholar
• Y Suzuki, Y Nagase, K Iga, M Kawase, M Oka, S Yanai, Y Matsumoto, S Nakagawa, T Fukuda, H Adachi, N Higo, and Y Ogawa. (2002). Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34). J. Pharm. Sci. 91:350–361.
   PubMed Web of Science ®Google Scholar
• X Liu, GJ Pettway, LK McCauley, and PX Ma. (2007). Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials. 28:4124–4131.
   PubMed Web of Science ®Google Scholar
• CG Bellows, H Ishida, JE Aubin, and JN Heersche. (1990). Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology. 127:3111–3116.
   PubMed Web of Science ®Google Scholar